Download FREE Report Sample
Download Free samplePeanuts are one of the food allergens most commonly associated with anaphylaxis, a sudden and potentially deadly condition that requires immediate attention and treatment.
Peanut Allergy Therapeutics Market contains market size and forecasts of Peanut Allergy Therapeutics in Global, including the following market information:
Global Peanut Allergy Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Peanut Allergy Therapeutics market was valued at 698 million in 2021 and is projected to reach US$ 5942.9 million by 2028, at a CAGR of 35.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Epinephrine Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Peanut Allergy Therapeutics include Mylan, Bayer, UCB Pharma, J & J, Perrigo, GSK, Kaleo, Amneal Pharma and ALK Abello, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Peanut Allergy Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peanut Allergy Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Peanut Allergy Therapeutics Market Segment Percentages, by Type, 2021 (%)
Epinephrine Injection
Antihistamines
Oral Immunotherapy
Other
Global Peanut Allergy Therapeutics Market, by Distribution Channel, 2017-2022, 2023-2028 ($ millions)
Global Peanut Allergy Therapeutics Market Segment Percentages, by Distribution Channel, 2021 (%)
Hospital Pharmacy
Retail Pharmacy
Other
Global Peanut Allergy Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Peanut Allergy Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peanut Allergy Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Peanut Allergy Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mylan
Bayer
UCB Pharma
J & J
Perrigo
GSK
Kaleo
Amneal Pharma
ALK Abello
Aimmune Therapeutics
HUAPONT Pharm
Allergy Therapeutics
ASIT Biotech
Sanofi
DBV Technologies
HAL Allergy
Intrommune Therapeutics
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
